Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-03-22

Clinical Trial Update: Prevalence of Hyperuricemia in Pakistan

View source ↗

Summary

This clinical trial update reports on the prevalence of hyperuricemia in Pakistan, sponsored by OBS Pakistan; the current status of the study is listed as unkno…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: OBS Pakistan | Conditions: Hyperuricemia | Status: UNKNOWN